Medical devices that use artificial intelligence (AI) and machine learning (ML) will be a major focus of guidance development undertaken by the FDA’s Center for Devices and Radiological Health (CDRH) over the next 12 months. On Oct. 10, the center released its guidance development priorities for fiscal year (FY) 2024, which extends to the end of September 2024. As in previous... Read More